HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection
Conditions
- Hepatitis B
- Liver Transplantation
Interventions
- DRUG: HepeX-B
- DRUG: Hepatitis B Immune Globulin (HBIg)
Sponsor
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)